Promoting ectopic pancreatic fates: Pancreas development and future diabetes therapies

Clinical Genetics

Volumn 74, Issue 4, 2008, Pages 316-324

  Pearl, E J ^a   Horb, Marko E ^a,b,c,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cell replacement therapy; Ngn3; Pancreas; Pdx1; Ptf1a; Stem cells; Transdifferentiation; Xenopus zebrafish

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HOMEODOMAIN PROTEIN; NEOGENIN; PROTEIN ARX; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR PTF1A; UNCLASSIFIED DRUG; WNT PROTEIN;

CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL TRANSPLANTATION; CELL TYPE; DIABETES MELLITUS; EMBRYONIC STEM CELL; ENDOCRINE CELL; GENE EXPRESSION; HUMAN; MEDICAL RESEARCH; NONHUMAN; ORGANOGENESIS; PANCREAS CELL; PANCREAS FUNCTION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATOR GENE; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE DIFFERENTIATION; XENOPUS; ZEBRA FISH;

ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; PANCREAS; TRANSCRIPTION FACTORS;

DANIO RERIO;

EID: 52449134197     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01081.x     Document Type: Review

References (98)

1. Banting FG, Best CH, Collip JB et al. Pancreatic extracts in the treatment of diabetes mellitus: Preliminary report. Can Med Assoc J 1922: 12: 141-146.
2. Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn 2004: 229: 176-200.
3. Murtaugh LC. Pancreas and beta-cell development: From the actual to the possible. Development 2007: 134: 427-438.
4. Cano DA, Hebrok M, Zenker M. Pancreatic development and disease. Gastroenterology 2007: 132: 745-762.
5. Kelly OG, Melton DA. Development of the pancreas in Xenopus laevis. Dev Dyn 2000: 218: 615-627.
6. Jorgensen MC, Ahnfelt-Ronne J, Hald J et al. An illustrated review of early pancreas development in the mouse. Endocr Rev 2007: 28: 685-705.
7. Ober EA, Field HA, Stainier DY. From endoderm formation to liver and pancreas development in zebrafish. MechDev 2003: 120: 5-18.
8. Lin JW, Biankin AV, Horb ME et al. Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev Biol 2004: 274: 491-503.
9. Jarikji ZH, Vanamala S, Beck CW et al. Differential ability of Ptf1a and Ptf1a-VP16 to convert stomach, duodenum and liver to pancreas. Dev Biol 2007: 304: 786-799.
10. Horb ME, Shen CN, Tosh D et al. Experimental conversion of liver to pancreas. Curr Biol 2003: 13: 105-115.
11. Field HA, Dong PD, Beis D et al. Formation of the digestive system in zebrafish. II. Pancreas morphogenesis. Dev Biol 2003: 261: 197-208.
12. Blitz IL, Andelfinger G, Horb ME. Germ layers to organs: Using Xenopus to study "later"development. SeminCell Dev Biol 2006: 17: 133-145.
13. Afelik S, Chen Y, Pieler T. Combined ectopic expression of Pdx1 and Ptf1a/p48 results in the stable conversion of posterior endoderm into endocrine and exocrine pancreatic tissue. Genes Dev 2006: 20: 1441-1446.
14. Wright CV, Schnegelsberg P, De Robertis EM. XlHbox 8: A novel Xenopus homeo protein restricted to a narrow band of endoderm. Development 1989: 105: 787-794.
15. Leonard J, Peers B, Johnson T et al. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol 1993: 7: 1275-1283.
16. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 1993: 12: 4251-4259.
17. Miller CP, McGehee RE Jr, Habener JF. IDX-1: A new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 1994: 13: 1145-1156.
18. Peshavaria M, Gamer L, Henderson E et al. XIHbox 8, an endoderm-specific Xenopus homeodomain protein, is closely related to a mammalian insulin gene transcription factor. Mol Endocrinol 1994: 8: 806-816.
19. Polak M, Bouchareb-Banaei L, Scharfmann R et al. Early pattern of differentiation in the human pancreas. Diabetes 2000: 49: 225-232.
20. Spagnoli FM, Brivanlou AH. The Gata5 target, TGIF2, defines the pancreatic region by modulating BMP signals within the endoderm. Development 2008: 135: 451-461.
21. McLin VA, Rankin SA, Zorn AM. Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development 2007: 134: 2207-2217.
22. Stafford D, Hornbruch A, Mueller PR et al. A conserved role for retinoid signaling in vertebrate pancreas development. Dev Genes Evol 2004: 214: 432-441.
23. Moriya N, Komazaki S, Takahashi S et al. In vitro pancreas formation from Xenopus ectoderm treated with activin and retinoic acid. Dev Growth Differ 2000: 42: 593-602.
24. Molotkov A, Molotkova N, Duester G. Retinoic acid generated by Raldh2 in mesoderm is required for mouse dorsal endodermal pancreas development. Dev Dyn 2005: 232: 950-957.
25. Martin M, Gallego-Llamas J, Ribes V et al. Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant mice. Dev Biol 2005: 284: 399-411.
26. van den Brink GR. Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev 2007: 87: 1343-1375.
27. Hebrok M. Hedgehog signaling in pancreas development. Mech Dev 2003: 120: 45-57.
28. Pan FC, Chen Y, Bayha E et al. Retinoic acid-mediated patterning of the pre-pancreatic endoderm in Xenopus operates via direct and indirect mechanisms. Mech Dev 2007: 124: 518-531.
29. Chen Y, Pan FC, Brandes N et al. Retinoic acid signaling is essential for pancreas development and promotes endocrine at the expense of exocrine cell differentiation in Xenopus. Dev Biol 2004: 271: 144-160.
30. Zhang J, Rosenthal A, de Sauvage FJ et al. Downregulation of Hedgehog signaling is required for organogenesis of the small intestine in Xenopus. Dev Biol 2001: 229: 188-202.
31. Hebrok M, Kim SK, Melton DA. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev 1998: 12: 1705-1713.
32. Roy S, Qiao T, Wolff C et al. Hedgehog signaling pathway is essential for pancreas specification in the zebrafish embryo. Curr Biol 2001: 11: 1358-1363.
33. diIorio PJ, Moss JB, Sbrogna JL et al. Sonic hedgehog is required early in pancreatic islet development. Dev Biol 2002: 244: 75-84.
34. Chung WS, Stainier DY. Intra-endodermal interactions are required for pancreatic beta cell induction. Dev Cell 2008: 14: 582-593.
35. Jacquemin P, Lemaigre FP, Rousseau GG. The onecut transcription factor HNF-6 (OC-1) is required for timely specification of the pancreas and acts upstream of Pdx-1 in the specification cascade. Dev Biol 2003: 258: 105-116.
36. Jacquemin P, Durviaux SM, Jensen J et al. Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol 2000: 20: 4445-4454.
37. Offield MF, Jetton TL, Labosky PA et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996: 122: 983-995.
38. Jonsson J, Carlsson L, Edlund T et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994: 371: 606-609.
39. Ahlgren U, Jonsson J, Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/ PDX1-deficient mice. Development 1996: 122: 1409-1416.
40. Stoffers DA, Zinkin NT, Stanojevic V et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997: 15: 106-110.
41. Schwitzgebel VM, Mamin A, Brun T et al. Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. J Clin Endocrinol Metab 2003: 88: 4398-4406.
42. Yee NS, Yusuff S, Pack M. Zebrafish pdx1 morphant displays defects in pancreas development and digestive organ chirality, and potentially identifies a multipotent pancreas progenitor cell. Genesis 2001: 30: 137-140.
43. Kawaguchi Y, Cooper B, Gannon M et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 2002: 32: 128-134.
44. Krapp A, Knofler M, Ledermann B et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev 1998: 12: 3752-3763.
45. Wiebe PO, Kormish JD, Roper VT et al. Ptf1a binds to and activates area III, a highly conserved region of the Pdx1 promoter that mediates early pancreas-wide Pdx1 expression. Molecular and cellular biology 2007: 27: 4093-4104.
46. Burlison JS, Long Q, Fujitani Y et al. Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cells. Dev Biol 2008: 316: 74-86.
47. Masui T, Long Q, Beres TM et al. Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex. Genes Dev 2007: 21: 2629-2643.
48. Zecchin E, Mavropoulos A, Devos N et al. Evolutionary conserved role of ptf1a in the specification of exocrine pancreatic fates. Dev Biol 2004: 268: 174-184.
49. Sellick GS, Barker KT, Stolte-Dijkstra I et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 2004: 36: 1301-1305.
50. Fodor A, Harel C, Fodor L et al. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: An ex vivo gene therapy approach. Diabetologia 2007: 50: 121-130.
51. Meivar-Levy I, Sapir T, Gefen-Halevi S et al. Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein beta. Hepatology 2007: 46: 898-905.
52. Shternhall-Ron K, Quintana FJ, Perl S et al. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun 2007: 28: 134-142.
53. Miyatsuka T, Kaneto H, Shiraiwa T et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev 2006: 20: 1435-1440.
54. Fukuda A, Kawaguchi Y, Furuyama K et al. Ectopic pancreas formation in Hes1-knockout mice reveals plasticity of endodermal progenitors of the gut, bile duct, and pancreas. J Clin Invest 2006: 116: 1484-1493.
55. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002: 129: 2447-2457.
56. Esni F, Ghosh B, Biankin AV et al. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004: 131: 4213-4224.
57. Seymour PA, Freude KK, Tran MN et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A 2007: 104: 1865-1870.
58. Lynn FC, Smith SB, Wilson ME et al. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A 2007: 104: 10500-10505.
59. Schwitzgebel VM, Scheel DW, Conners JR et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000: 127: 3533-3542.
60. Gradwohl G, Dierich A, LeMeur M et al. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 2000: 97: 1607-1611.
61. Mellitzer G, Bonne S, Luco RF et al. IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas. EMBO J 2006: 25: 1344-1352.
62. Gierl MS, Karoulias N, Wende H et al. The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev 2006: 20: 2465-2478.
63. Apelqvist A, Li H, Sommer L et al. Notch signalling controls pancreatic cell differentiation. Nature 1999: 400: 877-881.
64. Johansson KA, Dursun U, Jordan N et al. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 2007: 12: 457-465.
65. Collombat P, Mansouri A, Hecksher-Sorensen J et al. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev 2003: 17: 2591-2603.
66. Collombat P, Hecksher-Sorensen J, Krull J et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J Clin Invest 2007: 117: 961-970.
67. Sosa-Pineda B, Chowdhury K, Torres M et al. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997: 386: 399-402.
68. Collombat P, Hecksher-Sorensen J, Broccoli V et al. The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas. Development 2005: 132: 2969-2980.
69. Ait-Lounis A, Baas D, Barras E et al. Novel function of the ciliogenic transcription factor RFX3 in development of the endocrine pancreas. Diabetes 2007: 56: 950-959.
70. Wierup N, Svensson H, Mulder H et al. The ghrelin cell: A novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002: 107: 63-69.
71. Prado CL, Pugh-Bernard AE, Elghazi L et al. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A 2004: 101: 2924-2929.
72. Wang Q, Elghazi L, Martin S et al. Ghrelin is a novel target of Pax4 in endocrine progenitors of the pancreas and duodenum. Dev Dyn 2008: 237: 51-61.
73. Heller RS, Jenny M, Collombat P et al. Genetic determinants of pancreatic epsilon-cell development. Dev Biol 2005: 286: 217-224.
74. Collombat P, Hecksher-Sorensen J, Serup P et al. Specifying pancreatic endocrine cell fates. Mechanisms of development 2006: 123: 501-512.
75. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev 2003: 120: 65-80.
76. Jun HS. Regeneration of pancreatic beta cells. Front Biosci 2008: 13: 6170-6182.
77. Phillips BW, Hentze H, Rust WL et al. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev 2007: 16: 561-578.
78. D'Amour KA, Bang AG, Eliazer S et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006: 24: 1392-1401.
79. Madsen OD. Stem cells and diabetes treatment. APMIS 2005: 113: 858-875.
80. Madsen OD, Serup P. Towards cell therapy for diabetes. Nat Biotechnol 2006: 24: 1481-1483.
81. Lu P, Liu F, Yan L et al. Stem cells therapy for type 1 diabetes. Diabetes Res Clin Pract 2007: 78: 1-7.
82. Karnieli O, Izhar-Prato Y, Bulvik S et al. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007: 25: 2837-2844.
83. Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003: 21: 763-770.
84. Gao X, Song L, Shen K et al. Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. Biochem Biophys Res Commun 2008: 371: 132-137.
85. Ai C, Todorov I, Slovak ML et al. Human marrow-derived mesodermal progenitor cells generate insulin-secreting islet-like clusters in vivo. Stem Cells Dev 2007: 16: 757-770.
86. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006: 103: 17438-17443.
87. Lee DD, Grossman E, Chong AS. Cellular therapies for type 1 diabetes. Horm Metab Res 2008: 40: 147-154.
88. Gao F, Wu DQ, Hu YH et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res 2008: 151: 293-302.
89. Robertson SA, Rowan-Hull AM, Johnson PR. The spleen -a potential source of new islets for transplantation? J Pediatr Surg 2008: 43: 274-278.
90. Bajada S, Mazakova I, Richardson JB et al. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008: 2: 169-183.
91. Gangaram-Panday ST, Faas MM, de Vos P. Towards stem-cell therapy in the endocrine pancreas. Trends Mol Med 2007: 13: 164-173.
92. Limbert C, Path G, Jakob F et al. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus. Diabetes Res Clin Pract 2008: 79: 389-399.
93. Slack JM, Tosh D. Transdifferentiation and metaplasia -switching cell types. Curr Opin Genet Dev 2001: 11: 581-586.
94. Tosh D, Slack JM. How cells change their phenotype. Nat Rev Mol Cell Biol 2002: 3: 187-194.
95. Tang DQ, Cao LZ, Chou W et al. Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiation. Lab Invest 2006: 86: 829-841.
96. Tang DQ, Lu S, Sun YP et al. Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors. Lab Invest 2006: 86: 83-93.
97. Bonner-Weir S, Inada A, Yatoh S et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans 2008: 36: 353-356.
98. Minami K, Seino S. Pancreatic acinar-to-beta cell transdifferentiation in vitro. Front Biosci 2008: 13: 5824-5837.